Figure 2From: DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volumeOverall survival. Kaplan-Maier plots for a) all patients; b) patients by tumor stage; c) patients by tumor size groups.Back to article page